Stabilized zirconia ceramics for dental applications
Copyright 2020 Biolife Sas. www.biolifesas.org..
The research is aiming to obtain at room temperature a new ceramic material containing partially stabilized zirconia with different oxides after sintering used for dental and other technological purposes. Our research proposes a new method based on the use of stabilized zirconia with other oxides to obtain optimized dental material with a lower cost price and / or improved properties to allow wider use of these products to an increased number of patients in dental offices. X-ray diffraction, SEM analysis. FTIR spectroscopy, UVVis and density measurements were accomplished for the three ceramic systems. The correlation between the microstructure and the spectroscopic properties of zirconium stabilized by FTIR spectroscopy, UV-Vis helps understanding the mechanisms associated with the formation of high (tetragonal and / or cubic) temperature zirconia. Along with the simple, less costly preparation method and high purity of the ceramic products our study offers a highly desirable product for technological applications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Journal of biological regulators and homeostatic agents - 35(2021), 2 Suppl. 1 vom: 27. März, Seite 241-251 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Manole, M [VerfasserIn] |
---|
Links: |
---|
Themen: |
C6V6S92N3C |
---|
Anmerkungen: |
Date Completed 21.07.2021 Date Revised 21.07.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.23812/21-2supp1-25 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328266248 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328266248 | ||
003 | DE-627 | ||
005 | 20231225202606.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.23812/21-2supp1-25 |2 doi | |
028 | 5 | 2 | |a pubmed24n1094.xml |
035 | |a (DE-627)NLM328266248 | ||
035 | |a (NLM)34281322 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Manole, M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Stabilized zirconia ceramics for dental applications |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.07.2021 | ||
500 | |a Date Revised 21.07.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright 2020 Biolife Sas. www.biolifesas.org. | ||
520 | |a The research is aiming to obtain at room temperature a new ceramic material containing partially stabilized zirconia with different oxides after sintering used for dental and other technological purposes. Our research proposes a new method based on the use of stabilized zirconia with other oxides to obtain optimized dental material with a lower cost price and / or improved properties to allow wider use of these products to an increased number of patients in dental offices. X-ray diffraction, SEM analysis. FTIR spectroscopy, UVVis and density measurements were accomplished for the three ceramic systems. The correlation between the microstructure and the spectroscopic properties of zirconium stabilized by FTIR spectroscopy, UV-Vis helps understanding the mechanisms associated with the formation of high (tetragonal and / or cubic) temperature zirconia. Along with the simple, less costly preparation method and high purity of the ceramic products our study offers a highly desirable product for technological applications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a SEM | |
650 | 4 | |a UltraViolet-Visible | |
650 | 4 | |a XRD | |
650 | 4 | |a dental ceramic | |
650 | 4 | |a infrared spectroscopy | |
650 | 4 | |a tetragonal zirconia | |
650 | 4 | |a zirconia vitroceramics | |
650 | 7 | |a Zirconium |2 NLM | |
650 | 7 | |a C6V6S92N3C |2 NLM | |
650 | 7 | |a zirconium oxide |2 NLM | |
650 | 7 | |a S38N85C5G0 |2 NLM | |
700 | 1 | |a Dinu, C |e verfasserin |4 aut | |
700 | 1 | |a Inchingolo, A D |e verfasserin |4 aut | |
700 | 1 | |a Rada, S |e verfasserin |4 aut | |
700 | 1 | |a Bordea, L R |e verfasserin |4 aut | |
700 | 1 | |a Inchingolo, A M |e verfasserin |4 aut | |
700 | 1 | |a Malcangi, G |e verfasserin |4 aut | |
700 | 1 | |a Marinelli, G |e verfasserin |4 aut | |
700 | 1 | |a D'Oria, M T |e verfasserin |4 aut | |
700 | 1 | |a Scarano, A |e verfasserin |4 aut | |
700 | 1 | |a Lorusso, F |e verfasserin |4 aut | |
700 | 1 | |a Dipalma, G |e verfasserin |4 aut | |
700 | 1 | |a Baciu, S |e verfasserin |4 aut | |
700 | 1 | |a Inchingolo, F |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of biological regulators and homeostatic agents |d 1989 |g 35(2021), 2 Suppl. 1 vom: 27. März, Seite 241-251 |w (DE-627)NLM012600660 |x 0393-974X |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2021 |g number:2 Suppl. 1 |g day:27 |g month:03 |g pages:241-251 |
856 | 4 | 0 | |u http://dx.doi.org/10.23812/21-2supp1-25 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2021 |e 2 Suppl. 1 |b 27 |c 03 |h 241-251 |